|Amgen Inc -- USA Stock|| |
USD 192.33 3.05 1.61%
Senior Vice President General Counsel, Secretary
Mr. Jonathan P. Graham is Senior Vice President, General Counsel, Secretary of the Company. Prior to joining the Company, From July 2006 to May 2015, Mr. Graham was Senior Vice President and General Counsel at Danaher Corporationrationration. From October 2004 to June 2006, Mr. Graham was Vice President, Litigation and Legal Policy at General Electric Company . Prior to GE, Mr. Graham was a partner at Williams Connolly LLP.
Age: 55 President Since 2015
805 447-1010 www.amgen.com
Jonathan Graham Latest Insider Activity
The company has return on total asset (ROA)
of 7.92 %
which means that it generated profit of $7.92 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE)
of 25.96 %
meaning that it created $25.96 on every $100 dollars invested by stockholders.
The company currently holds 35.78 B in liabilities with Debt to Equity (D/E) ratio of 111.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.95 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.